Humana Ozempic Coverage: A Medicare-Heavy Insurer's Approach

Trust signals

> Reviewed by FormBlends Medical Team · Last updated May 2026 · 11 sources cited · As of May 2026, confirm directly with your plan

Key Takeaways

• Humana's plan mix is heavily weighted toward Medicare Advantage and Part D, with commercial group plans and Tricare administration as smaller lines
• Ozempic is covered for type 2 diabetes across most Humana plan types with prior authorization
• The 2025 Inflation Reduction Act $2,000 Part D out-of-pocket cap meaningfully changed cost exposure for Medicare members
• Off-label Ozempic prescribing for weight loss is not covered; patients should pursue Wegovy under its own indication
• Humana Military administers Tricare East Region but does not directly determine Tricare drug coverage

Direct answer

Humana covers Ozempic for adults with type 2 diabetes across its commercial, Medicare Advantage, and Part D plans, subject to prior authorization. Coverage requires documented diabetes diagnosis and typically prior metformin trial. Medicare members benefit from the 2025 Inflation Reduction Act $2,000 annual Part D out-of-pocket cap. Off-label use for weight loss is not covered. Verify with your specific Humana plan.

Table of contents

1. Humana's plan portfolio
2. Medicare Advantage Part D Ozempic coverage
3. The 2025 IRA out-of-pocket cap
4. Standalone Part D plans
5. Humana commercial group plans
6. Humana Medicaid managed care
7. Humana Military and Tricare
8. Prior authorization mechanics
9. Cost scenarios
10. Appealing a Humana denial
11. Decision framework
12. FAQ
13. Sources

Humana's plan portfolio

Humana, Inc. operates as one of the largest Medicare-focused insurers in the United States. Approximately 80% of Humana's medical membership is concentrated in Medicare lines of business, including Medicare Advantage and Part D standalone plans. Commercial group employer business is a smaller share, and Humana announced in 2023 a strategic exit from much of its commercial group market to focus on government programs.

The Medicare focus has implications for Ozempic coverage. Humana's pharmacy team has substantial expertise navigating Part D rules, including coverage gaps, formulary tier placement, and the recent Inflation Reduction Act changes. Commercial members may find Humana's pharmacy benefit administration less specialized than dedicated commercial insurers.

Humana's pharmacy benefit is administered through Humana Pharmacy Solutions, the in-house PBM, rather than through Express Scripts, Caremark, or OptumRx. Formulary decisions are made internally.

Medicare Advantage Part D Ozempic coverage

Humana Medicare Advantage plans (HMO and PPO) with prescription drug coverage typically place Ozempic on a tier 3 or tier 4 specialty tier with prior authorization. PA criteria align with the FDA-approved type 2 diabetes indication.

Coverage requirements typically include:

• Documented type 2 diabetes diagnosis
• A1c value documented within the past 6 months
• Prior trial of metformin or documented metformin intolerance/contraindication
• For step therapy plans, prior trial of preferred GLP-1 alternative

Some Humana MA plans include a "diabetes-care kit" benefit structure, with additional supports for members on chronic disease therapies. Continuation of Ozempic coverage at annual reauthorization requires documentation of continued diagnosis and clinical response.

The 2025 IRA out-of-pocket cap

The Inflation Reduction Act of 2022 established a $2,000 annual out-of-pocket cap for Medicare Part D, effective January 2025. The cap applies cumulatively across all Part D-covered prescriptions.

For Humana Medicare Part D and MA-PD members on Ozempic, the practical effect is significant. A member with an Ozempic tier 4 copay of approximately $100 monthly would historically have accumulated substantial out-of-pocket spend through the coverage gap. Under the IRA cap, the member's total Part D out-of-pocket spending is limited to $2,000 across all medications.

Members can also enroll in the Medicare Prescription Payment Plan, which allows monthly smoothing of out-of-pocket costs across the calendar year rather than front-loaded payments.

Standalone Part D plans

Humana offers standalone Part D plans (PDPs) for Medicare members who retain Original Medicare for medical coverage but seek prescription drug coverage separately. The Humana Premier PDP and Humana Walmart Value PDP are common offerings.

Ozempic coverage in Humana PDPs follows similar PA criteria as MA-PD plans. The IRA cap applies. Plan-specific formulary placement, tier structure, and copay amounts vary across the PDP product lines.

Members shopping standalone PDPs should compare Ozempic-specific tier placement, PA requirements, and any preferred pharmacy network restrictions across available plans.

Humana commercial group plans

Humana's remaining commercial business is concentrated in certain regional employer groups. Coverage rules for Ozempic in commercial Humana plans typically follow standard PBM logic:

• Tier 2 or tier 3 formulary placement
• Prior authorization required
• Type 2 diabetes diagnosis documentation
• Step therapy in some employer-customized plans

Self-funded employer plans administered by Humana can impose additional restrictions or exclusions. Members should consult their Summary Plan Description for plan-specific rules.

Humana Medicaid managed care

Humana operates Medicaid managed care in a smaller number of states than competitors like Centene or UnitedHealthcare. Ozempic coverage in Humana Medicaid plans follows the underlying state Medicaid drug list.

State Medicaid programs typically cover Ozempic for type 2 diabetes with PA. Step therapy and prior trial requirements vary. Medicaid members should consult their state Medicaid drug list for specific criteria.

Humana Military and Tricare

Humana Military is a separate operating segment that administers Tricare East Region under contract with the Department of Defense. Tricare provides healthcare coverage to active-duty military, retirees, and dependents.

Tricare prescription benefits are managed through Express Scripts (the Tricare Pharmacy Program contractor), not through Humana directly. Humana Military's role is primarily medical claims administration and member services for the East Region.

For Tricare members seeking Ozempic coverage, the relevant rules come from Tricare and Express Scripts, not from Humana's commercial or Medicare formulary. Tricare typically covers Ozempic for type 2 diabetes with PA.

Prior authorization mechanics

Humana Pharmacy Solutions PA for Ozempic generally proceeds as follows:

1. Prescriber submits PA request through Humana's provider portal or CoverMyMeds
2. Required documentation: T2DM diagnosis (ICD-10), A1c, prior therapy history
3. Clinical review against Humana's GLP-1 coverage criteria
4. Decision typically within 24 to 72 hours for standard requests; expedited review available for urgent cases
5. Approval period: 12 months typically

Denials cite specific reasons: missing diagnosis, inadequate A1c, lack of prior therapy. Each denial reason has a specific remediation pathway.

Cost scenarios

Plan type	Approximate monthly Ozempic cost
Medicare Advantage Part D, covered	$40 to $100 monthly, $2,000 annual cap
Standalone Part D, covered	$40 to $100 monthly, $2,000 annual cap
Commercial covered, tier 2	$25 to $50
Commercial covered, tier 3	$50 to $100
Commercial with Novo copay card	$25
Uncovered cash retail	Approximately $1,000
Humana Medicaid covered	$0 to nominal copay

Important: Medicare beneficiaries are not eligible for the Novo Nordisk commercial copay card. The copay card is restricted to commercial insurance members.

Appealing a Humana denial

Denial appeals follow Medicare or commercial appeal pathways depending on plan type.

Medicare Advantage or Part D appeals:

1. Coverage determination redetermination request to Humana (Level 1)
2. Reconsideration by Independent Review Entity (Level 2)
3. Administrative Law Judge hearing (Level 3)
4. Medicare Appeals Council review (Level 4)
5. Federal district court review (Level 5)

Each level has specific deadlines. Standard appeals must be filed within 60 days of denial. Expedited appeals are available for urgent cases.

Commercial appeals: Internal Humana review, then external review through state Independent Review Organization. ERISA self-funded plans have separate Department of Labor appeal procedures.

Decision framework

If you have Humana Medicare Advantage with T2DM: Pursue PA through your prescriber. The IRA cap meaningfully reduces total out-of-pocket exposure. Approval is typical when criteria met.

If you have Humana commercial coverage with T2DM: Standard PA pathway applies. Check whether your employer plan has additional step therapy or exclusions.

If you have Humana Medicaid with T2DM: State Medicaid drug list controls. Coverage is typical with PA.

If you have Tricare via Humana Military: Tricare/Express Scripts rules apply, not Humana commercial rules.

If you do not have T2DM and want semaglutide for weight loss: Pursue Wegovy through Humana coverage (if available) rather than off-label Ozempic. Note that Medicare Part D generally excludes weight-loss drugs except under the CV indication for established heart disease.

What to verify before using this answer

The useful next step for Humana Ozempic Coverage: A Medicare-Heavy Insurer's Approach is to verify the details that can change the decision: current labeling, insurance rules, pharmacy instructions, dose timing, contraindications, and whether the evidence applies to your diagnosis rather than only to weight loss headlines.

For this coverage and access page, the most relevant search terms are does, humana, cover, ozempic. Those terms point to a practical decision, so the answer should be checked against a current prescription label, payer policy, trial result, or clinician recommendation before you act.

FormBlends keeps this page focused on patient-level decision points: what is known, what is uncertain, what should be handled by a licensed clinician, and what should be avoided because it creates dosing, safety, or access risk.

FAQ

Does Humana cover Ozempic? Yes, for T2DM with prior authorization, across most plan types.

What plans does Humana offer? MA, Part D PDP, commercial group, Medicaid managed care in select states, and Tricare East via Humana Military.

Does Humana Medicare cover Ozempic? Yes, with PA, subject to $2,000 IRA out-of-pocket cap.

What is Humana's prior authorization for Ozempic? T2DM diagnosis, A1c documentation, prior metformin therapy.

How much does Ozempic cost with Humana? Covered Medicare: $40 to $100 monthly, $2,000 cap. Covered commercial: $25 to $100.

Will Humana cover Ozempic for weight loss? No.

What is Humana Military's role? Tricare East Region administrator; not directly responsible for Tricare drug formulary.

Does the IRA cap apply to Ozempic? Yes, for Medicare Part D members.

Sources

1. FDA, Ozempic (semaglutide) prescribing information, December 2017 initial approval
2. Inflation Reduction Act of 2022, Part D out-of-pocket cap provisions, effective January 2025
3. Centers for Medicare and Medicaid Services, Part D coverage rules and formulary requirements
4. Humana Drug List (Formulary), 2026 plan year editions across Medicare and commercial
5. Humana Pharmacy Solutions clinical criteria, GLP-1 coverage policies, 2025-2026
6. Tricare Pharmacy Program Formulary, administered by Express Scripts
7. Marso SP et al. SUSTAIN-6 cardiovascular outcomes trial. New England Journal of Medicine. 2016
8. American Diabetes Association, Standards of Care in Diabetes, 2026 edition
9. State Medicaid drug lists, accessed May 2026
10. Medicare Prescription Payment Plan, CMS implementation materials, 2025
11. Humana, Inc. 2024 annual report, Medicare line of business disclosures

Footer disclaimers

Platform Disclaimer. FormBlends connects patients with licensed clinicians and 503A pharmacies. FormBlends is not affiliated with Humana, Inc., Humana Pharmacy Solutions, Novo Nordisk, Tricare, or any government healthcare program. Coverage information reflects publicly available data as of May 2026.

Compounded Medication Notice. Compounded semaglutide is a 503A pharmacy preparation made for individual patients. It is not FDA-approved and is not therapeutically equivalent to brand Ozempic, Wegovy, or Rybelsus.

Results Disclaimer. Glycemic and cardiovascular outcomes vary by individual. Trial data reflects average effects in study populations. A1c reduction, weight change, and CV event rate effects are not guaranteed.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Humana is a registered trademark of Humana, Inc. Tricare is a registered service mark of the Department of Defense. Express Scripts is a registered trademark of Express Scripts Holding Company.